Bellemin Jean-Marc Insider Trades

Insider Trading History

Track insider trading activity for Bellemin Jean-Marc. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $265k 60,529 shares
Last Trade
Jun 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$7.86k 4,464 shares
$1.76
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $269k 61,528 shares
Last Trade
Jun 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.5k 8,789 shares
$1.76
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $285k 64,993 shares
Last Trade
Jun 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.5k 8,789 shares
$1.76
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $411k 93,750 shares
Last Trade
Mar 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$380k 93,750 shares
$4.05
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $385k 87,938 shares
Last Trade
Mar 03, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$237k 58,590 shares
$4.04
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $246k 56,204 shares
Last Trade
Mar 03, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$128k 31,734 shares
$4.04
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $308k 70,317 shares
Last Trade
Mar 03, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$237k 58,590 shares
$4.04
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $103k 23,437 shares
Last Trade
Sep 03, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$254k 23,438 shares
$10.85
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $181k 41,239 shares
Last Trade
Sep 03, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$254k 23,438 shares
$10.85
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $129k 29,348 shares
Last Trade
Sep 03, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$129k 11,891 shares
$10.85
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $739k 168,750 shares
Last Trade
Mar 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 168,750 shares
$7.12
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $124k 28,354 shares
Last Trade
Jan 03, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$115k 18,850 shares
$6.11
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $78k 17,801 shares
Last Trade
Jan 03, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$64.5k 10,553 shares
$6.11
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jan 03, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$115k 18,850 shares
$6.11
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $41.6k 9,504 shares
Last Trade
Jun 14, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$72.2k 9,346 shares
$7.73
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $82.6k 18,850 shares
Last Trade
Jun 14, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$146k 18,850 shares
$7.73
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $82.6k 18,850 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$146k 18,850 shares
$7.73
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $591k 135,000 shares
Last Trade
Jan 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.09M 135,000 shares
$15.49
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $165k 37,700 shares
Last Trade
Jun 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$900k 37,700 shares
$23.87
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $657k 150,000 shares
Last Trade
Dec 14, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.54M 150,000 shares
$50.26
$4.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up